Observational studyThe oncologist2024

Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08).

Yu Sunakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.